trending Market Intelligence /marketintelligence/en/news-insights/trending/l8JEQojTQX4AdMOpRvPIig2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

SunTrust Robinson Humphrey initiates coverage of National Health Investors Inc. at 'hold'

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate CRE Sector Feels the Impact of the Coronavirus

Credit Analytics Case Study Poundworld Retail Ltd


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

SunTrust Robinson Humphrey initiates coverage of National Health Investors Inc. at 'hold'

SunTrust Robinson Humphrey Capital Markets analystEric J.Fleming initiated coverage of National Health Investors Inc. with a rating of"hold," and a price target of $80.

The analyst wrote in a research report: "With one ofthe lowest levered balance sheets in the healthcare REIT space (4.3x) and asolid growth track record, we believe NHI will continue to leverage its strongcost of capital position towards accretive acquisitions. With a stellar balancesheet, we think NHI is well positioned to take advantage of opportunities inthe market and further leverage its deep operator relationships to drive steadyinvestment growth."